tirzepatide not losing weight How Does Work for Loss? Tirzepatide vs. Semaglutide: Key Differences

Q13: Is tesamorelin a controlled or scheduled drug

2014 Oct;74(4):875-82

The double-blind multicenter phase 3 trials STEP 1, 3, 4, 5 were conducted in adults (mean age 46.247.3 years), mostly females, with obesity or overweight with 1 weight-related complication (mean BMI 37.838.4 kg/m 2 ) and aimed to demonstrate the superiority of semaglutide 2.4 mg over placebo in BW lowering at 68 or 104 24 weeks as an adjunct to diet and physical activity 23

The results of these two studies indicate that the MCT supplementation may affect the energy metabolism and neurotransmission in the brain, however the effects may be region- and phenotype-specific